APA (7th ed.) Citation

Tianrui Yang, Ziren Kong, & Wenbin Ma. (2021). PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: Clinical studies, challenges and potential. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Tianrui Yang, Ziren Kong, and Wenbin Ma. PD-1/PD-L1 Immune Checkpoint Inhibitors in Glioblastoma: Clinical Studies, Challenges and Potential. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Tianrui Yang, et al. PD-1/PD-L1 Immune Checkpoint Inhibitors in Glioblastoma: Clinical Studies, Challenges and Potential. Taylor & Francis Group, 2021.